# Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)

> **NCT06228508** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06228508
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2024-05
- **Final completion:** 2024-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06228508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06228508, "Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06228508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*